Literature DB >> 30590753

Treatment of refractory adult onset Still's disease with combination anakinra and baricitinib therapy.

Chayma Ladhari1, Christian Jorgensen1,2, Yves-Marie Pers1,2.   

Abstract

Entities:  

Year:  2019        PMID： 30590753     DOI： 10.1093/rheumatology/key414

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  8 in total

1.  Effectiveness and Safety of JAK Inhibitors in Autoinflammatory Diseases: A Systematic Review.

Authors:  Zhivana Boyadzhieva; Nikolas Ruffer; Gerd Burmester; Anne Pankow; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 2.  Progress in Biological Therapies for Adult-Onset Still's Disease.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Paolo Sfriso
Journal:  Biologics       Date:  2022-04-21

3.  Tofacitinib in refractory adult-onset Still's disease: 14 cases from a single centre in China.

Authors:  Qiongyi Hu; Mengyan Wang; Jinchao Jia; Jialin Teng; Huihui Chi; Tingting Liu; Hong-Lei Liu; Xiaobing Cheng; Junna Ye; Yutong Su; Yue Sun; Zhuochao Zhou; Liyan Wan; Zhihong Wang; Fan Wang; Hui Shi; Chengde Yang
Journal:  Ann Rheum Dis       Date:  2020-02-20       Impact factor: 19.103

Review 4.  Anakinra in children and adults with Still's disease.

Authors:  Sebastiaan J Vastert; Yvan Jamilloux; Pierre Quartier; Sven Ohlman; Lisa Osterling Koskinen; Torbjörn Kullenberg; Karin Franck-Larsson; Bruno Fautrel; Fabrizio de Benedetti
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

5.  Adult-Onset Still's Disease: A Case Report and Review of Current Therapeutic Options.

Authors:  Steffi Thomas; Vartika Kesarwani; Melanie Graber; Weishali Joshi
Journal:  Cureus       Date:  2022-03-01

Review 6.  Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases.

Authors:  Adam Al-Hakim; Anoop Mistry; Sinisa Savic
Journal:  J Inflamm Res       Date:  2022-10-10

Review 7.  Rare, rarer, lung involvement in adult-onset Still's disease: A mini-review.

Authors:  Jasper F Nies; Udo Schneider; Martin Krusche
Journal:  Front Med (Lausanne)       Date:  2022-09-16

Review 8.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.